A Reappraisal of Thymosin Alpha1 in Cancer Therapy

A Reappraisal of Thymosin Alpha1 in Cancer Therapy

Thymosin alpha1 (Tα1), an endogenous peptide first isolated from the thymic tissue in the mid-sixties, has gained considerable attention for its immunostimulatory activity that led to its application to diverse pathological conditions, including cancer. Studies in animal models and human patients ha...

Full description

Bibliographic Details
Main Authors: Claudio Costantini, Marina M. Bellet, Marilena Pariano, Giorgia Renga, Claudia Stincardini, Allan L. Goldstein, Enrico Garaci, Luigina Romani
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-09-01
Series:Frontiers in Oncology
Subjects:
thymosin alpha1
checkpoint inhibitors
immunotherapy
colitis
dendritic cells
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00873/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.00873/full

Similar Items